The aim is that of developing global guidance for the air cargo industry to enable optimal transportation of the COVID-19 vaccine. The guidance will be developed gradually in four work packages through a joint working group to ensure feedback from all stakeholders in the supply chain of air cargo and pharmaceuticals.
In the past few months, air freight has demonstrated once again its vital role in the global economy and distribution of essential medical supplies. In the months to come, air freight will again make an important contribution to the global public good and in fighting this pandemic by playing a vital role in the COVID-19 vaccine global supply chain. As pharmaceutical companies race to develop the COVID-19 vaccine, it is still unclear what impact this vaccine will have on the global supply chain, more specifically, that of logistics requirements and the air cargo industry.
To address these concerns, the joint working group will bring to the table all the key industry stakeholders, including pharmaceutical manufacturers and logistics businesses. The aim of this programme is to provide the air cargo industry with more clarity of the demands, expectations and quality supply chain requirements, including but not restricted to, critical trade lanes, air cargo capacity, handling and storage, as well as track and trace requirements for the transportation of the vaccines.
